Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
clavulanate (Augmentin) (1 trial)
faropenem medoxomil (Fropenem) (1 trial)
meropenem (merrem) (1 trial)
procaine benzylpenicillin (novocaine) (1 trial)
pyrazinamide (Aldinamide) (1 trial)
Tuberculosis (Phase 2)
Tuberculosis, Pulmonary (Phase 2)
Trials (1 total)
Trial APIs (5 total)